ISRG - CIK 0001035267
The table below shows INTUITIVE SURGICAL INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $911.90M | $581.60M | $265.40M | $371.40M | $223.00M | $477.60M |
| Capital expenditure | - | - | - | - | - | - |
| Investing cash flow | -$914.50M | $213.50M | -$128.50M | $573.10M | -$214.70M | -$597.00M |
| Dividends paid | - | - | - | - | - |
INTUITIVE SURGICAL INC reported operating cash flow of $3.03B for fiscal year 2025. That is up 25.5% from $2.42B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $1.09B (FY 2016) to $3.03B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $1.12B | $0.00 | $0.00 | $350.00M | $106.50M | $0.00 |
| Financing cash flow | -$1.35B | -$235.80M | -$46.70M | -$381.20M | -$199.90M | -$102.20M |